Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b
Comparative study published in Biochim Biophys Acta (1994)
Abstract
The genes for chymotrypsin inhibitors 1a and 1b (CI-1a and CI-1b) from barley have been expressed in E. coli, and the CI-1a and CI-1b proteins purified. These proteins, although highly homologous, differ in the active site region at P2, P1' and P3' (Schechter and Berger nomenclature), and so might be expected to have differing specificities. Despite this, analysis of the inhibition kinetics showed that each displayed very similar kinetic behaviour when tested against a range of proteinases. The specificity of the CI-1 proteins is different to that of the other main barley inhibitor, CI-2, and Ki values are found to follow the series subtilisin Carlsberg < neutrophil elastase approximately subtilisin BPN' << chymotrypsin. Only very weak inhibition is found of trypsin, and pancreatic elastase is not measurably inhibited. For the proteinases inhibited most strongly, characteristic slow-binding inhibition kinetics were observed, whereas classical inhibition applied to the weaker interactions. The results are consistent with the major determinant of specificity being the P1 residue of the inhibitor, which is the same in both CI-1a and CI-1b. Consistent with this, is the similar spectrum of specificity found for the homologous inhibitor eglin c from leech, which has the same P1 residue. Both the CI-1 proteins are found to be less stable than CI-2, with CI-1a being significantly less stable than CI-1b as measured by guanidinium hydrochloride unfolding experiments. Possible reasons for the reduced stability are discussed in view of the sequence differences between CI-1a, CI-1b and CI-2.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Comparison of barley chymotrypsin inhibitors with leech eglin c; eglin c shares similar P1 residue specificity for subtilisin and neutrophil elastase.
Por qué esto importa para la hirudoterapia
Este estudio comparativo expresó y purificó los inhibidores de quimotripsina de cebada CI-1a y CI-1b en E. coli y caracterizó su cinética de inhibición frente a un conjunto de proteasas, hallando un comportamiento similar entre ambos a pesar de las diferencias en la secuencia del sitio activo, con una especificidad determinada principalmente por el residuo P1 compartido. El estudio solo es tangencialmente relevante para el dominio de ASH: señala brevemente que el inhibidor homólogo eglina c de la sanguijuela comparte el mismo residuo P1 y un espectro de especificidad similar, pero el trabajo en sí versa sobre inhibidores de proteasas vegetales, no sobre sanguijuelas ni hirudoterapia. El resumen no formula afirmaciones terapéuticas ni aporta datos derivados de sanguijuelas. La advertencia honesta es que este artículo no involucra experimentos con sanguijuelas, ni análisis del secretoma de la sanguijuela, ni relevancia para la hirudoterapia más allá de una comparación estructural pasajera; su inclusión en una biblioteca de ASH se limitaría a un valor contextual indirecto sobre las relaciones estructura-actividad de los inhibidores.
Citación
Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b.
Greagg MA et al. · Biochim Biophys Acta, 1994
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026